{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:42:43Z","timestamp":1760838163623,"version":"build-2065373602"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001043","name":"Cass Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001043","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000972","name":"Australian Agency for International Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000972","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.bmc.2019.115260","type":"journal-article","created":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T20:39:24Z","timestamp":1576269564000},"page":"115260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Formaldehyde-activated WEHI-150 induces DNA interstrand crosslinks with unique structural features"],"prefix":"10.1016","volume":"28","author":[{"given":"Paul P.","family":"Pumuye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benny J.","family":"Evison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shyam K.","family":"Konda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Grant","family":"Collins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celine","family":"Kelso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jelena","family":"Medan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brad E.","family":"Sleebs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Watson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Don R.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne M.","family":"Cutts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2019.115260_b0005","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrc1529","article-title":"Timeline: chemotherapy and the war on cancer","volume":"5","author":"Chabner","year":"2005","journal-title":"Nat Rev Can"},{"key":"10.1016\/j.bmc.2019.115260_b0010","first-page":"396","article-title":"Chemical cross-linking of drugs to DNA","volume":"340","author":"Luce","year":"2001","journal-title":"MethodsEnzymol"},{"key":"10.1016\/j.bmc.2019.115260_b0015","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1021\/bi00230a002","article-title":"Formaldehyde cross-links daunorubicin and DNA efficiently: HPLC and X-ray diffraction studies","volume":"30","author":"Wang","year":"1991","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2019.115260_b0020","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1016\/S0040-4020(01)81782-8","article-title":"Sequence preferences of DNA interstrand cross-linking agents \u2013 importance of minimal DNA structural reorganization in the cross-linking reactions of mechlorethamine, cisplatin, and Mitomycin-C","volume":"47","author":"Hopkins","year":"1991","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bmc.2019.115260_b0025","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3727\/096504005776382305","article-title":"Formaldehyde-releasing prodrugs in combination with adriamycin can overcome cellular drug resistance","volume":"15","author":"Cutts","year":"2005","journal-title":"Oncol Res"},{"key":"10.1016\/j.bmc.2019.115260_b0030","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1124\/mol.108.045625","article-title":"Formaldehyde-activated pixantrone is a monofunctional DNA alkylator that binds selectively to CpG and CpA doublets","volume":"74","author":"Evison","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bmc.2019.115260_b0035","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.2174\/1568026615666150413154512","article-title":"Potential therapeutic advantages of doxorubicin when activated by formaldehyde to function as a DNA adduct-forming agent","volume":"15","author":"Cutts","year":"2015","journal-title":"Curr Topics Med Chem"},{"key":"10.1016\/j.bmc.2019.115260_b0040","first-page":"8194","article-title":"Molecular basis for the synergistic interaction of adriamycin with the formaldehyde-releasing prodrug pivaloyloxymethyl butyrate (AN-9)","volume":"61","author":"Cutts","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.bmc.2019.115260_b0045","doi-asserted-by":"crossref","first-page":"7648","DOI":"10.1021\/jm050678v","article-title":"Doxazolidine, a proposed active metabolite of doxorubicin that cross-links DNA","volume":"48","author":"Post","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.115260_b0050","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1093\/nar\/27.14.2918","article-title":"Formation of DNA adducts by formaldehyde-activated mitoxantrone","volume":"27","author":"Parker","year":"1999","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bmc.2019.115260_b0055","first-page":"1125","article-title":"Production of formaldehyde from N5-methyltetrahydrofolate by normal and leukemic leukocytes","volume":"37","author":"Thorndike","year":"1977","journal-title":"Cancer Res"},{"key":"10.1016\/j.bmc.2019.115260_b0060","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1007\/s40265-016-0650-8","article-title":"Pixantrone: a review in relapsed or refractory aggressive non-Hodgkin's lymphoma","volume":"76","author":"Keating","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.bmc.2019.115260_b0065","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1093\/nar\/gkm285","article-title":"Pixantrone can be activated by formaldehyde to generate a potent DNA adduct forming agent","volume":"35","author":"Evison","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bmc.2019.115260_b0070","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/nar\/28.4.982","article-title":"Formaldehyde activation of mitoxantrone yields CpG and CpA specific DNA adducts","volume":"28","author":"Parker","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bmc.2019.115260_b0075","doi-asserted-by":"crossref","first-page":"18814","DOI":"10.1074\/jbc.M400931200","article-title":"A molecular understanding of mitoxantrone-DNA adduct formation: effect of cytosine methylation and flanking sequences","volume":"279","author":"Parker","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2019.115260_b0080","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.1093\/nar\/gkp700","article-title":"CpG methylation potentiates pixantrone and doxorubicin-induced DNA damage and is a marker of drug sensitivity","volume":"37","author":"Evison","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bmc.2019.115260_b0085","doi-asserted-by":"crossref","first-page":"15953","DOI":"10.1074\/jbc.M009216200","article-title":"Cytosine methylation enhances mitoxantrone-DNA adduct formation at CpG dinucleotides","volume":"276","author":"Parker","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2019.115260_b0090","first-page":"115","article-title":"Correlation of DNA reactivity and cytotoxicity of a new class of anticancer agents: aza-anthracenediones","volume":"91","author":"Hazlehurst","year":"1995","journal-title":"CancerLett"},{"key":"10.1016\/j.bmc.2019.115260_b0095","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.bcp.2011.08.013","article-title":"M2, a novel anthracenedione, elicits a potent DNA damage response that can be subverted through checkpoint kinase inhibition to generate mitotic catastrophe","volume":"82","author":"Evison","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmc.2019.115260_b0100","doi-asserted-by":"crossref","first-page":"6851","DOI":"10.1021\/jm901894c","article-title":"New anthracenedione derivatives with improved biological activity by virtue of stable drug-DNA adduct formation","volume":"53","author":"Mansour","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.115260_b0105","doi-asserted-by":"crossref","first-page":"10217","DOI":"10.1039\/C6OB02100J","article-title":"Isolation and structural analysis of the covalent adduct formed between a bis-amino mitoxantrone analogue and DNA: a pathway to major-minor groove cross-linked adducts","volume":"14","author":"Konda","year":"2016","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.bmc.2019.115260_b0110","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.1039\/C6OB00561F","article-title":"Reversible and formaldehyde-mediated covalent binding of a bis-amino mitoxantrone analogue to DNA","volume":"14","author":"Konda","year":"2016","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.bmc.2019.115260_b0115","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1093\/nar\/21.8.1857","article-title":"Thermal stability of DNA adducts induced by cyanomorpholinoadriamycin in vitro","volume":"21","author":"Cullinane","year":"1993","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bmc.2019.115260_b0120","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1021\/jm9013407","article-title":"Mitoxantrone analogues as ligands for a stem-loop structure of tau pre-mRNA","volume":"52","author":"Liu","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.115260_b0125","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.abb.2008.05.009","article-title":"Mass spectrometric investigation of the DNA-binding properties of an anthracycline with two trisaccharide chains","volume":"477","author":"Kelso","year":"2008","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.bmc.2019.115260_b0130","first-page":"432","article-title":"Oligonucleotide probes for the screening of recombinant DNA libraries","volume":"152","author":"Wallace","year":"1987","journal-title":"MethodsEnzymol"},{"key":"10.1016\/j.bmc.2019.115260_b0135","doi-asserted-by":"crossref","first-page":"5972","DOI":"10.1039\/C5OB00526D","article-title":"Binding of pixantrone to DNA at CpA dinucleotide sequences and bulge structures","volume":"13","author":"Konda","year":"2015","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.bmc.2019.115260_b0140","first-page":"466","article-title":"High-resolution transcription assay for probing drug-DNA interactions at individual drug sites","volume":"340","author":"Phillips","year":"2001","journal-title":"MethodsEnzymol"},{"key":"10.1016\/j.bmc.2019.115260_b0145","unstructured":"Sambrook JF, Russell DW. Molecular Cloning: A Laboratory Manual. Molecular Cloning: A Laboratory Manual: Cold Spring Harbour Laboratory Press; 2001. Vol. 1\u20133."},{"issue":"23","key":"10.1016\/j.bmc.2019.115260_b0150","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.1039\/c0ob00295j","article-title":"DNA binding by pixantrone","volume":"8","author":"Adnan","year":"2010","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.bmc.2019.115260_b0155","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jinorgbio.2011.09.025","article-title":"Platinum-DNA interstrand crosslinks: molecular determinants of bending and unwinding of the double helix","volume":"108","author":"Suchankova","year":"2012","journal-title":"J Inorg Biochem"},{"issue":"23","key":"10.1016\/j.bmc.2019.115260_b0160","doi-asserted-by":"crossref","first-page":"7355","DOI":"10.1021\/bi00371a017","article-title":"Kinetics and sequence specificity of drug-DNA interactions: an in vitro transcription assay","volume":"25","author":"Phillips","year":"1986","journal-title":"Biochemistry"},{"issue":"6","key":"10.1016\/j.bmc.2019.115260_b0165","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3727\/096504003773994815","article-title":"Formation of mitoxantrone adducts in human tumor cells: potentiation by AN-9 and DNA methylation","volume":"14","author":"Parker","year":"2004","journal-title":"Oncol Res"},{"issue":"7","key":"10.1016\/j.bmc.2019.115260_b0170","first-page":"661","article-title":"Sequence specificity of adriamycin-DNA adducts in human tumor cells","volume":"2","author":"Cutts","year":"2003","journal-title":"Mol Cancer Ther"},{"issue":"5","key":"10.1016\/j.bmc.2019.115260_b0175","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2174\/18715206113136660361","article-title":"The potential of acridine carboxamide Pt complexes as anti-cancer agents: a review","volume":"14","author":"Murray","year":"2014","journal-title":"Antican Agents Med Chem"},{"issue":"2","key":"10.1016\/j.bmc.2019.115260_b0180","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/med.21364","article-title":"Mitoxantrone, more than just another topoisomerase II poison","volume":"36","author":"Evison","year":"2016","journal-title":"Med Res Rev"},{"issue":"7","key":"10.1016\/j.bmc.2019.115260_b0185","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nrc3088","article-title":"DNA interstrand crosslink repair and cancer","volume":"11","author":"Deans","year":"2011","journal-title":"Nat Rev Cancer"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089619311502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089619311502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:06:38Z","timestamp":1760835998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089619311502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0968089619311502"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2019.115260","relation":{},"ISSN":["0968-0896"],"issn-type":[{"type":"print","value":"0968-0896"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Formaldehyde-activated WEHI-150 induces DNA interstrand crosslinks with unique structural features","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2019.115260","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115260"}}